Log in

OTCMKTS:BOPH - Bohai Pharmaceuticals Group Stock Price, Forecast & News

$0.0010
0.00 (0.00 %)
(As of 03/11/2019)
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.00
Volume50,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta1.78
Bohai Pharmaceuticals Group, Inc. engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine. Its products include lung nourishing syrup, tongbi capsules, tongbi tablets, zhuangyuanshenhailong medicinal wine, bazhenyimu cream, fangfengtongsheng granule, and zhengxintai capsules. The company was founded on January 9, 2008 and is headquartered in Yantai, China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BOPH
CUSIP097316103
Phone86-53-5685-7928

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive BOPH News and Ratings via Email

Sign-up to receive the latest news and ratings for BOPH and its competitors with MarketBeat's FREE daily newsletter.


Bohai Pharmaceuticals Group (OTCMKTS:BOPH) Frequently Asked Questions

What is Bohai Pharmaceuticals Group's stock symbol?

Bohai Pharmaceuticals Group trades on the OTCMKTS under the ticker symbol "BOPH."

Has Bohai Pharmaceuticals Group been receiving favorable news coverage?

Media headlines about BOPH stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Bohai Pharmaceuticals Group earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Bohai Pharmaceuticals Group.

Who are some of Bohai Pharmaceuticals Group's key competitors?

Who are Bohai Pharmaceuticals Group's key executives?

Bohai Pharmaceuticals Group's management team includes the folowing people:
  • Mr. Hongwei Qu, Founder, Chairman, CEO, Pres, Principal Financial Officer and GM (Age 43)
  • Ms. Chunhong Jiang, Sec. and Treasurer (Age 53)

How do I buy shares of Bohai Pharmaceuticals Group?

Shares of BOPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Bohai Pharmaceuticals Group's stock price today?

One share of BOPH stock can currently be purchased for approximately $0.00.

What is Bohai Pharmaceuticals Group's official website?

The official website for Bohai Pharmaceuticals Group is http://www.bohaipharma.com/.

How can I contact Bohai Pharmaceuticals Group?

Bohai Pharmaceuticals Group's mailing address is C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD ZHIFU DISTRICT, YANTAI F4, 264000. The company can be reached via phone at 86-53-5685-7928 or via email at [email protected]


MarketBeat Community Rating for Bohai Pharmaceuticals Group (OTCMKTS BOPH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  61
MarketBeat's community ratings are surveys of what our community members think about Bohai Pharmaceuticals Group and other stocks. Vote "Outperform" if you believe BOPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BOPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Featured Article: Call Option

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel